150 related articles for article (PubMed ID: 9071822)
1. IgD monoclonal gammopathy of undetermined significance.
Kinoshita T; Nagai H; Murate T; Saito H; Fukatsu T; Hotta T
Int J Hematol; 1997 Feb; 65(2):169-72. PubMed ID: 9071822
[TBL] [Abstract][Full Text] [Related]
2. [Primary amyloidosis associated with IgD-lambda M-proteinemia].
Kimura S; Iwatsuka R; Aoki T; Odawara J; Asada N; Yamakura M; Takeuchi M; Matsue K
Rinsho Ketsueki; 2007 Dec; 48(12):1555-8. PubMed ID: 18203516
[TBL] [Abstract][Full Text] [Related]
3. IgD monoclonal gammopathy with long-term follow-up.
Bladé J; Kyle RA
Br J Haematol; 1994 Oct; 88(2):395-6. PubMed ID: 7803288
[TBL] [Abstract][Full Text] [Related]
4. [IgD-lambda type multiple myeloma associated with IgG-kappa type benign monoclonal gammopathy].
Shimada H; Nishinarita S; Kishigami Y; Hayama T; Sawada U; Horie T; Nakamura N; Kato M; Hirano M; Nakamura O
Nihon Rinsho Meneki Gakkai Kaishi; 1995 Apr; 18(2):235-40. PubMed ID: 7553059
[TBL] [Abstract][Full Text] [Related]
5. AL amyloidosis with IgD-lambda monoclonal gammopathy and lambda-type Bence-Jones protein: successful treatment by autologous stem cell transplantation.
Sakurai-Chin C; Ubara Y; Suwabe T; Hoshino J; Yonaha T; Hasegawa E; Sumida K; Hiramatsu R; Yamanouchi M; Hayami N; Yamauchi J; Tominaga N; Sawa N; Takemoto F; Masuoka K; Takaichi K; Oohashi K
Clin Exp Nephrol; 2010 Oct; 14(5):506-10. PubMed ID: 20632063
[TBL] [Abstract][Full Text] [Related]
6. The monoclonal gammopathies.
Kyle RA
Clin Chem; 1994 Nov; 40(11 Pt 2):2154-61. PubMed ID: 7955402
[TBL] [Abstract][Full Text] [Related]
7. IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay.
Djidjik R; Lounici Y; Chergeulaïne K; Berkouk Y; Mouhoub S; Chaib S; Belhani M; Ghaffor M
Pathol Biol (Paris); 2015 Sep; 63(4-5):210-4. PubMed ID: 26294067
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin D benign monoclonal gammopathy. A case report.
O'Connor ML; Rice DT; Buss DH; Muss HB
Cancer; 1991 Aug; 68(3):611-6. PubMed ID: 1905973
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal gammopathy of undetermined significance and solitary plasmacytoma. Implications for progression to overt multiple myeloma.
Kyle RA
Hematol Oncol Clin North Am; 1997 Feb; 11(1):71-87. PubMed ID: 9081205
[TBL] [Abstract][Full Text] [Related]
10. [A long-term observation of development from monoclonal gammopathy of undetermined significance (MGUS) into primary amyloidosis].
Kanoh T; Yago K; Okuma M
Rinsho Ketsueki; 1990 Oct; 31(10):1740-4. PubMed ID: 2255066
[TBL] [Abstract][Full Text] [Related]
11. Kidney failure as an unusual initial presentation of biclonal gammopathy (IgD multiple myeloma associated with light chain disease)--a case report.
Rabrenović V; Mijušković Z; Marjanović S; Rabrenović M; Jovanović D; Antić S; Ignjatović L; Petrović M; Pilcević D
Vojnosanit Pregl; 2015 Feb; 72(2):196-9. PubMed ID: 25831916
[TBL] [Abstract][Full Text] [Related]
12. IgD myeloma: a potential missed diagnosis.
Sinclair D; Cranfield T
Ann Clin Biochem; 2001 Sep; 38(Pt 5):564-5. PubMed ID: 11587138
[TBL] [Abstract][Full Text] [Related]
13. Prognosis in monoclonal gammopathy of undetermined significance.
Vuckovic J; Ilic A; Knezevic N; Marinkovic M; Zemunik T; Dubravcic M
Br J Haematol; 1997 Jun; 97(3):649-51. PubMed ID: 9207414
[TBL] [Abstract][Full Text] [Related]
14. [Systemic amyloidosis associated with IgD-λ multiple myeloma].
Nagamachi Y; Yamauchi N; Muramatsu H; Inomata H; Nozawa E; Koyama R; Ihara K; Nishisato T; Yamada H; Yano T; Kikuchi S; Hirako T; Kitaoka K; Ono K; Ihara H; Kato J
Rinsho Ketsueki; 2011 Dec; 52(12):1888-92. PubMed ID: 22241157
[TBL] [Abstract][Full Text] [Related]
15. IgD-λ multiple myeloma with excessive excretion of free light chains: a diagnostic trap in the identification of monoclonal gammopathies.
Zahir H; Tali A; Rachidi M; Mouhib H; Daif H; Ait Ouzdi Z; Haouach K; Chabaa L
Ann Biol Clin (Paris); 2019 Feb; 77(1):107-111. PubMed ID: 30799291
[TBL] [Abstract][Full Text] [Related]
16. [Expression of microRNA-221/222 in patients with monoclonal gammopathy of undetermined significance and multiple myeloma].
Yang S; Wang W; Jin H; Zhong Y; Xie X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(4):371-378. PubMed ID: 27868410
[TBL] [Abstract][Full Text] [Related]
17. [A case of monoclonal gammapathy type IgD].
Salcedo Garayalde E; Rosino Rodríguez A; Hernández Laguna T; Ortega Vasalo B
An Med Interna; 1996 Nov; 13(11):544-6. PubMed ID: 9019214
[TBL] [Abstract][Full Text] [Related]
18. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Rajkumar SV; Lacy MQ; Kyle RA
Blood Rev; 2007 Sep; 21(5):255-65. PubMed ID: 17367905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
